Condition

Churg Strauss Syndrome (3)

Giant Cell Arteritis (1)

Microscopic Polyangiitis (1)

Polyarteritis Nodosa (1)

Takayasu Arteritis (1)

Wegener's Granulomatosis (1)

Overall Status

Completed (2)

Unknown status (1)

Sign in for free

Phase

phase 1/phase 2 (1)

phase 2 (1)

Sponsor

Brigham and Women's Hospital (1)

University Hospital Schleswig-Holstein (1)

University of Oxford (1)

Collaborator

GlaxoSmithKline (2)

American College of Rheumatology (1)

The European League Against Rheumatism (EULAR) (1)

The Vasculitis foundation (1)

Intervention

mepolizumab (2)

Study Documents

Publication (1)

Intervention Type

biological (1)

drug (1)

Funder Type

Other (3)

Study Type

Interventional (2)

Observational (1)

churg strauss syndrome

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Churg Strauss Syndrome Trial in Boston (Mepolizumab)

Completed

Has Results

Churg Strauss Syndrome

Mepolizumab

Boston, Massachusetts

Brigham and Women's Hospital

Feb 1, 2017

American College of Rheumatology/European League Against

Unknown status

Wegener's Granulomatosis
+5 more

Birmingham, Alabama
+119 more

Aug 18, 2016

Churg Strauss Syndrome Trial in Bad Bramstedt (mepolizumab)

Completed

Churg Strauss Syndrome

mepolizumab

Bad Bramstedt, SH, Germany

University Hospital Schleswig Holstein, Rheumaklinik Bad Bramste

Jun 14, 2012